JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 12.36% |
| 3 | Healthcare | 9.31% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Garrett Motion
GTX
$5.41B
| $1.31M | ﹤0.01% |
84,673
+18,834
| +29% | +$320K |
|
3527
The RMR Group
RMR
$346M
| $1.31M | ﹤0.01% |
29,914
+1,276
| +4% | +$68.7K |
|
3528
Piper Sandler
PIPR
$5.41B
| $1.31M | ﹤0.01% |
71,488
-88,428
| -55% | -$1.67M |
|
3529
Exponent
EXPO
$3.19B
| $1.31M | ﹤0.01% |
22,405
+1,957
| +10% | +$111K |
|
|
RFP
3530
DELISTED
Resolute Forest Products Inc.
RFP
| $1.3M | ﹤0.01% |
199,844
+193,660
| +3,132% | +$1.36M |
|
3531
CALL
T. Rowe Price
TROW
$23.6B
| $1.3M | ﹤0.01% |
12,000
-8,000
| -40% | -$842K |
|
|
3532
PUT
T. Rowe Price
TROW
$23.6B
| $1.3M | ﹤0.01% |
12,000
-8,000
| -40% | -$842K |
|
3533
Towne Bank
TOWN
$3.5B
| $1.3M | ﹤0.01% |
47,787
+425
| +0.9% | +$11.2K |
|
|
OXFD
3534
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.3M | ﹤0.01% |
94,354
+3,157
| +3% | +$48.3K |
|
3535
Ocular Therapeutix
OCUL
$2.2B
| $1.29M | ﹤0.01% |
292,947
+275,307
| +1,561% | +$1.02M |
|
3536
PUT
CF Industries
CF
$17.9B
| $1.29M | ﹤0.01% |
+27,400
| New | +$1.19M |
|
3537
Park Aerospace
PKE
$831M
| $1.29M | ﹤0.01% |
77,327
+34,960
| +83% | +$561K |
|
3538
Liberty Global Class A
LBTYA
$3.57B
| $1.28M | ﹤0.01% |
47,988
-407
| -0.8% | -$10.7K |
|
|
UCFC
3539
DELISTED
United Community Financial Corp
UCFC
| $1.28M | ﹤0.01% |
135,573
-2,462
| -2% | -$23K |
|
3540
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.99B
| $1.28M | ﹤0.01% |
42,090
+2,463
| +6% | +$74.4K |
|
|
CTLP
3541
DELISTED
Cantaloupe
CTLP
| $1.27M | ﹤0.01% |
177,558
+152,094
| +597% | +$942K |
|
3542
CALL
MPLX
MPLX
$60.3B
| $1.27M | ﹤0.01% |
+40,000
| New | +$1.27M |
|
|
3543
PUT
MPLX
MPLX
$60.3B
| $1.27M | ﹤0.01% |
+40,000
| New | +$1.27M |
|
3544
CALL
Zoom
ZM
$31.1B
| $1.27M | ﹤0.01% |
+14,100
| New | +$1.16M |
|
|
FPI
3545
Farmland Partners
FPI
$433M
| $1.27M | ﹤0.01% |
180,724
-34,162
| -16% | -$221K |
|
3546
PUT
Axsome Therapeutics
AXSM
$11.2B
| $1.27M | ﹤0.01% |
+50,000
| New | +$1M |
|
3547
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$619M
| $1.26M | ﹤0.01% |
24,639
+66
| +0.3% | +$3.34K |
|
|
CSR
3548
Centerspace
CSR
$938M
| $1.26M | ﹤0.01% |
21,890
+4,861
| +29% | +$289K |
|
3549
CALL
Halozyme
HALO
$11.2B
| $1.26M | ﹤0.01% |
75,000
+45,000
| +150% | +$726K |
|
3550
Oxford Industries
OXM
$543M
| $1.26M | ﹤0.01% |
17,086
-11,576
| -40% | -$886K |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.